Search

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

Abt Global can help public-and private-sector actors take decisive action to finance climate mitigation and adaptation strategies.

CMS contracted Abt to conduct the 2022 Nursing Home Staffing Study, and our findings informed the agency’s 2024 staffing policy.

Artificial intelligence (AI) is reshaping how we live, work, and interact with technology. As AI’s capabilities expand, so do its ethical and societal implications. In this master class, Dr. Nora Connor, Abt Global’s director of data science and AI, explores how AI evolved and how we can ensure its use for good.

Abt Global is presenting and exhibiting at the 2024 Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH).

Grantees of JPMorgan Chase’s PRO Neighborhoods Competition improved their finances so that they could address community needs equitably.